An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: Peginterferon alfa-2b;   Drug: RibavirinSponsors:   Vertex Pharmaceuticals Incorporated;   Janssen PharmaceuticalsCompleted - verified May 2015

Source: ClinicalTrials.gov - September 27, 2012 Category: Research Source Type: clinical trials